Evidence map›Paper›PMID 35989933›Full record

ReviewFrontiers in neurology2022

The application and perspective of hyperbaric oxygen therapy in acute ischemic stroke: From the bench to a starter?

Yujia Yan, Xiqiang Zhang, Xingwei An, Wanpeng Fan, Jingbo Liang, Bin Luo, Hecheng Ren, Ying Huang

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Hypoxia as a medicine.Science translational medicine · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yujia YanAcademy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, China.
Xiqiang ZhangDepartment of Neurosurgery, Third People's Hospital of Xining City, Xining, China.
Xingwei AnAcademy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, China.
Wanpeng FanDepartment of Neurosurgery, Third People's Hospital of Xining City, Xining, China.
Jingbo LiangDepartment of Neurosurgery, Third People's Hospital of Xining City, Xining, China.
Bin LuoDepartment of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China.
Hecheng RenDepartment of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China.
Ying HuangDepartment of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China.
Tianjin Huanhu Hospital · CNTianjin Medical University · CNTianjin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stroke has become a significant cause of death and disability globally. Along with the transition of the world's aging population, the incidence of acute ischemic stroke is increasing year by year. Even with effective treatment modalities, patients are not guaranteed to have a good prognosis. The treatment model combining intravenous thrombolysis/endovascular therapy and neuroprotection is gradually being recognized. After the clinical translation of pharmacological neuroprotective agents failed, non-pharmacological physical neuroprotective agents have rekindled hope. We performed a literature review using the National Center for Biotechnology Information (NCBI) PubMed database for studies that focused on the application of hyperbaric oxygen therapy in acute ischemic stroke. In this review, we present the history and mechanisms of hyperbaric oxygen therapy, focusing on the current status, outcomes, current challenges, perspective, safety, and complications of the application of hyperbaric oxygen in animal experiments and human clinical trials. Hyperbaric oxygen therapy, a non-pharmacological treatment, can improve the oxygenation level at the ischemic lesions in increased dissolved oxygen and oxygen diffusion radius to achieve salvage of neurological function, giving a new meaning to acute ischemic stroke.

Indexed as

acute ischemic strokeclinical applicationhyperbaric oxygen therapyneuroprotectionstroke

Identifiers

PMID35989933
PMCPMC9389005
OpenAlexW4289942383

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.